A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis
NCT ID: NCT01065090
Last Updated: 2015-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38 participants
OBSERVATIONAL
2010-06-30
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiple Sclerosis and Progressive Resistance Training
NCT01518660
Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis
NCT05562414
Evaluating Intervention Responsiveness in People With Multiple Sclerosis
NCT01632293
Effects of Resistance Training in Multiple Sclerosis: a Randomized Trial.
NCT06478784
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
NCT06270641
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
training
one group will receive resistance training and one group the normal physiotherapeutic treatment
No interventions assigned to this group
physiotherapy
one group will receive resistance training and one group the normal physiotherapeutic treatment
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Relapsing Remitting Multiple Sclerosis (RRMS) diagnosis according to McDonald Criteria
* Subjects who have been on Avonex treatment for 3-6 months prior to screening
* A signed informed consent form (ICF) is obtained before any study activity
* EDSS \> 1.5 and \< 5 at Screening with at least a score of 1 in pyramidal function
* Are able to walk at least 100 meters
* Are able to transport themselves to and from the training facility
Exclusion Criteria
* Have any serious medical co-morbidities like cardiovascular, respiratory, orthopedic or metabolic diseases
* Have had a MS relapse within an eight week period prior to the study start
* Are pregnant
* Have trained systematic resistance training for one day or more each week in the prior 3 months before study start.
* Only able to participate in less than 70% of the planned training sessions.
* Suffers from major depression
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biogen Idec A/S
UNKNOWN
Biogen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Director
Role: STUDY_DIRECTOR
Biogen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coordinating Research Site
NSW, , Australia
Research Site
Odense, , Denmark
Research Site
Sønderborg, , Denmark
Research Site
Vejle, , Denmark
Research Site
Jyväskylä, , Finland
Research Site
Oulu, , Finland
Research Site
Pori, , Finland
Research Site
Seinäjokï, , Finland
Research Site
Hamilton, , New Zealand
Research Site
Drammen, , Norway
Research Site
Ullevål, , Norway
Research Site
Ängelholm, , Sweden
Research Site
Gothenburg, , Sweden
Research Site
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACTIMS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.